AstraZeneca Says US Court Dismissed Lawsuit Without Prejudice Against FDA

AstraZeneca PLC (AZN) Is Rising After Reports Of Potential Pfizer Bid

AstraZeneca Unveils Nexium Direct-to-Patient Program - Quick Facts

AstraZeneca Closes Patient Enrollment Four Months Ahead Of Plan In EUCLID Study

AstraZeneca Sells Alderley Park Site In Cheshire

Trade AZN now with

3/26/2012 2:12 AM ET

AstraZeneca Plc (AZN: Quote,AZN.L) said that the US District Court denied the company's request for a preliminary injunction application against the FDA and dismissed the lawsuit without prejudice.

On March 23, the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the FDA regarding final marketing approval of generic quetiapine.

Notwithstanding the Court's decision, the company continues to believe strongly in the merits of its position and is evaluating its options.

Click here to receive FREE breaking news email alerts for AstraZeneca PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 203 Articles

Editors Pick

U.S. New Home Sales Unexpectedly Show Steep Drop In March

New home sales in the U.S. unexpectedly showed a substantial decrease in the month of March, according to a report released by the Commerce Department on Wednesday, with sales falling to their lowest level in eight months. The report said new home sales plunged 14.5 percent to an annual rate of 384,000 in March from the revised February rate of 449,000.

Eurozone Govt. Deficit Shrinks In 2013; Debt Rises

Euro area's government deficit shrunk last year to match the EU target, while public debt rose and remained above the official ceiling, figures from the Eurostat showed Wednesday. The shrunken government deficits suggest that euro area might be leaving behind the worst troubles of the financial crisis,...

Stocks May Give Back Ground Following Recent Upward Trend - U.S. Commentary

Following the strong upward move seen over the past few sessions, stocks may give back some ground in early trading on Wednesday. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 6 points.